CEPI (Coalition for Epidemic Preparedness Innovations)
About RVMC
In May 2022 CEPI, World Economic Forum (WEF) and the National Academy of Medicine, USA launched the RVMC to identify common needs and leading practices that facilitate the establishment of regional vaccine manufacturing efforts.
With the launch at Davos this year of RVMC “2.0” in support of regional manufacturing networks, the three organizations have agreed for CEPI to host the RVMC secretariat for the next 3 years. RVMC has developed a framework and generated case studies of what is needed for regionally led and economically sustainable manufacturing networks:
1. Sustainable business models during both pandemic and routine times
2. Scaled and shaped healthy markets supported by healthy market frameworks
3. De-risked returns to public-private partnerships through blended financial instruments
4. Fit for purpose manufacturing technologies and R&D models
5. Aligned and scalable tech transfer & workforce capability
6. Coordinated end-to-end supply chain infrastructure
7. Equitable regional governance model
8. Harmonized regulatory processes for accelerated access to markets
Countries and regions are calling for and taking actions to diversify vaccine manufacturing and supply chains; For example, the African Union has endorsed the Partnership for African Vaccine Manufacturing Framework for Action; and ASEAN published the Regional Strategic Plan for Vaccine Security and Self Reliance in 2021. The second phase of RVMC will provide bespoke support for regional leadership to establish economically sustainable vaccine manufacturing networks for both routine and future emergency response vaccine needs. CEPI will be the secretariat for RVMC from February 2024.
About CEPI
Launched in 2017, the Coalition for Epidemic Preparedness Innovations (CEPI) is an international coalition of governments, academic, philanthropic, private, public, and intergovernmental institutions whose vision is to create a world in which epidemics and pandemics are no longer a threat to humanity. Our mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. CEPI has played a central role in the global response to COVID-19, creating the world’s largest portfolio of COVID-19 vaccines and co-leading COVAX. CEPI has supported several scientific breakthroughs in vaccines development against other infectious diseases, including the investment in the first phase 3 trial of a Chikungunya vaccine, now FDA approved, and the first ever advancement of Nipah virus and Lassa virus vaccines candidates into phase 1 clinical trials.
CEPI has launched a plan to reduce the vaccine development timeline to a 100-day ‘moonshot’ target and to advance the development of broadly protective vaccines that can protect coronaviruses and other high risk viral families. The plans also calls for an improved global manufacturing capacity, particularly in lower income countries. New approaches to manufacturing need to be advanced to produce vaccines at the speed and scale needed to stamp out a pandemic threat (https://100days.cepi.net/). Manufacturers in South Africa, Senegal and Indonesia have partnered with CEPI to strengthen and broaden their capabilities, with further partnerships pending.
CEPI is a not-for-profit association under Norwegian Law and has offices in Oslo (HQ), London, and Washington DC.
In CEPI we strive for diverse thinking, and we want a diverse pool of candidates for all our vacancies. We work for an inclusive working environment where each employee can contribute and grow.
More details about CEPI and our mission can be found on our website: www.cepi.net
About the role
The Deputy Director will play a key role providing strategic management of the newly established RVMC 2.0 secretariat and RVMC 2.0 implementing agencies to ensure that the delivery of high-quality technical assistance meets the needs of regions. The position holder will develop and lead implementation of an RVMC 2.0 strategy to support regional leadership and plans for sustainable vaccine manufacturing networks. The post-holder will provide leadership and supportive management for the newly established RVMC 2.0 secretariat. The secretariat will include, 1 director, 1 deputy director, 2 project managers and 2-3 regional/technical leads and will coordinate a set of implementing agencies
This will be a 3-year Fixed Term Contract. The RVMC 2.0 Deputy Director will report to RVMC 2.0 Director.
Responsibilities
- Portfolio and budget management oversight for RVMC 2.0, including progress monitoring and budget development and implementation.
- Oversee development of an RVMC 2.0 results framework, working closely with Secretariat project managers, implementation agencies and partners. Ensure effective programme monitoring, review, reporting and adaptation systems are in place. Lead the project review process at end of year 2.
- Lead development and implementation of a stakeholder engagement plan to build the RVMC 2.0 network to support RVMC 2.0 strategy implementation. Provide strategic oversight of RVMC 2.0 implementing agencies on events and information management.
- Support the RVMC Director to develop and maintain priority partnership and stakeholder relationships.
- Support engagement with RVMC 2.0 governance, including any recruitment, support and active contributions to RVMC 2.0 (e.g. as champions).
- Potential line management responsibilities, to be agreed with the RVMC 2.0 director.
Education, Experience and Competence
- Advanced degree in public health, business administration, engineering or political science, providing a strong foundation for strategic leadership, business model analysis, stakeholder engagement and decision-making in the global health/vaccines landscape.
- Minimum 10 years in a senior position in vaccines manufacturing & supply chain, business development, regulatory, pharmacoeconomics and/or public affairs in a global environment, preferable experience based in Global South/LMIC regions.
- Experience in active and adaptive portfolio management to deliver strategic goals and objectives, including significant experience of managing consultancies to ensure effective and cost-efficient delivery.
- Experience in establishing/leading public-private partnerships.
- Proven collaboration skills, including managing shared project implementation and problem solving.
- Excellent policy advocacy and engagement strategy development and implementation experience, including high-impact convening and communications oversight.
- Excellent supportive team management skills.
- Awareness of cultural, equality, diversity and inclusion aspects involved in international teams and partner collaboration.
- Able to handle confidential information with complete discretion.
Travel and Location Requirements
- This will be a Norway (Oslo) or UK (London) based role with extensive international travel anticipated (up to 40%)
What we can offer you
- The opportunity to work as part of a highly motivated and expert team playing a leading role in international efforts to develop vaccines against emerging infectious diseases and accelerating development, supply scale-up and equitable access to vaccines for epidemic and pandemic threats
- The opportunity to work together with leading internal and external experts on solutions for global challenges
- A diverse and inclusive work force
How to apply
- For more information on how to apply, please visit: https://cepisites.secure.force.com/careers
- Should you have any issues submitting your application or have questions please contact [email protected]
- Background verification maybe conducted to verify information provided in the CV and available documentation.
- Deadline for receiving applications is 4th February 2024 at 23:59 CET
To apply for this job please visit cepi.net.